Inventor · Irvine, CA, US

Jeffrey L. Edelman

22Patents
4h-index
17Co-inventors
56Inventor score

Filing activity: Apr 30, 2004 → Sep 10, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US8512738B2 Biodegradable intravitreal tyrosine kinase implants Human Necessities 58 Active
US7771742B2 Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods Emerging Cross-Sectional Technologies 37 Active
US8062657B2 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues Emerging Cross-Sectional Technologies 26 Active
US8968766B2 Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods Emerging Cross-Sectional Technologies 19 Active
US7749530B2 Kinase inhibitors Chemistry; Metallurgy 4 Active
US9233070B2 Biodegradable intravitreal tyrosine kinase implants Human Necessities 3 Active
US8906892B2 4-pregenen-11β-17-21-triol-3,20-dione derivatives Human Necessities 3 Active
US8840872B2 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues Emerging Cross-Sectional Technologies 3 Active
US8865691B2 Pharmaceutical compositions and methods of use 4-pregenen-11β-17-21-triol-3,20-dione derivatives Human Necessities 3 Active
US9433631B2 4-pregenen-11β-17-21-triol-3,20-dione derivatives Human Necessities 3 Active
US9259429B2 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues Emerging Cross-Sectional Technologies 2 Active
US8455656B2 Kinase inhibitors Human Necessities 2 Active
US10076492B2 Biodegradable intravitreal tyrosine kinase implants Human Necessities 2 Active
US8143410B2 Kinase inhibitors Emerging Cross-Sectional Technologies 1 Active
US9717743B2 Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives Human Necessities 1 Active
US10881608B2 Biodegradable intravitreal tyrosine kinase implants Human Necessities 0 Active
US10188665B2 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues Emerging Cross-Sectional Technologies 0 Active
US10493082B2 4-pregenen-11β-17-21-triol-3,20-dione derivatives Human Necessities 0 Active
US8969583B2 3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors Chemistry; Metallurgy 0 Active
US9820995B2 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues Emerging Cross-Sectional Technologies 0 Active
US10188667B2 Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives Human Necessities 0 Active
US8383825B2 Kinase inhibitors Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.